The growing issue of novel psychoactive substances (NPS), often dubbed "designer drugs," presents a major challenge to global public health and law enforcement. These substances, frequently manufactured to circumvent existing drug laws, rapidly appear on the scene and are marketed as "legal highs" or "research chemicals," tempting individuals, part